Literature DB >> 2871101

Structure and mechanism of action of teicoplanin.

F Parenti.   

Abstract

The chemistry, structure and physicochemical properties of the novel glycopeptide teicoplanin are reviewed. The possible relationship between these characteristics and the mechanism and mode of action and pharmacokinetic behaviour are briefly discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2871101     DOI： 10.1016/0195-6701(86)90011-3

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


  22 in total

Review 1.  Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors:  Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

2.  Effects of the new glycopeptide antibiotic teicoplanin on platelet function and blood coagulation.

Authors:  G Agnelli; M Longetti; R Guerciolini; F Menichetti; S Grasselli; F Boldrini; G Bucaneve; G G Nenci; A Del Favero
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 3.  A risk-benefit assessment of teicoplanin in the treatment of infections.

Authors:  F de Lalla; A Tramarin
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

4.  Teicoplanin-induced leucopenia with immediate resolution after administration of G-CSF.

Authors:  Peysh Patel; Jonathan Sandoe; Wazir Baig
Journal:  BMJ Case Rep       Date:  2012-08-13

5.  Teicoplanin metabolism in rats.

Authors:  L F Zerilli; L Cavenaghi; A Bernareggi; A Assandri
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 6.  Structure, biochemistry and mechanism of action of glycopeptide antibiotics.

Authors:  P E Reynolds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

Review 7.  Clinical pharmacokinetics of teicoplanin.

Authors:  M Rowland
Journal:  Clin Pharmacokinet       Date:  1990-03       Impact factor: 6.447

Review 8.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

9.  Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.

Authors:  A Del Favero; F Menichetti; R Guerciolini; G Bucaneve; F Baldelli; F Aversa; A Terenzi; S Davis; S Pauluzzi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

10.  Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach.

Authors:  Nicoleta J Economou; Isaac J Zentner; Edwin Lazo; Jean Jakoncic; Vivian Stojanoff; Stephen D Weeks; Kimberly C Grasty; Simon Cocklin; Patrick J Loll
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.